In 2 mouse models of pulmonary fibrosis, thyroid hormone administration improved mitochondrial biogenesis and bioenergetics, leading to amelioration of pulmonary fibrosis, an effect mediated through PGC1α and PINK1 (40). Here, PPARGC1A is linked to pulmonary fibrosis.